Protalix BioTherapeutics

PLX

Börsenwert 205 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 BlackRock New York	6,15 Mio. $	+438.989 $	+282.272	+9 %
2	2 State Street Boston, Massachusetts	1,47 Mio. $	+103.587 $	+66.607	+9 %
3	3 Geode Capital Management Boston, Massachusetts	1,29 Mio. $	+37.891 $	+24.364	+3 %
4	4 Renaissance Technologies New York	1,18 Mio. $	+69.206 $	+44.500	+7 %
5	5 GSA Capital Partners London, United Kingdom	969.000 $	+73.805 $	+47.457	+10 %
6	6 Northern Trust Chicago, Illinois	879.743 $	+136.494 $	+87.766	+22 %
7	7 Vanguard Group Malvern, Pennsylvania	538.781 $	+33.138 $	+21.308	+8 %
8	8 Nuveen Charlotte, North Carolina	483.795 $	+15.107 $	+9.714	+4 %
9	9 Morgan Stanley New York	444.109 $	+78.794 $	+50.665	+25 %
10	10 Bridgeway Capital Management Houston, Texas	371.646 $	+77.760 $	+50.000	+31 %
11	11 Bank of America Charlotte, North Carolina	361.549 $	+46.194 $	+29.703	+17 %
12	12 Bank of New York Mellon New York	317.721 $	+19.930 $	+12.815	+8 %
13	13 Charles Schwab San Francisco, California	273.339 $	–	–	–
14	14 Barclays London, United Kingdom	223.750 $	+123.158 $	+79.191	+170 %
15	15 Goldman Sachs New York	185.967 $	-5.162 $	-3.319	-3 %
16	16 Susquehanna International Group Bala Cynwyd, Pennsylvania	183.785 $	+160.574 $	+103.250	Neu
17	17 Denali Advisors San Diego, California	168.566 $	-24.106 $	-15.500	-14 %
18	OGF 18 Orin Green Financial San Diego, California	142.400 $	–	–	–
19	19 UBS Group Zurich, Switzerland	132.998 $	+58.566 $	+37.658	+102 %
20	20 RhumbLine Advisers Boston, Massachusetts	131.155 $	-33.774 $	-21.717	-23 %
21	21 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	126.362 $	-150.148 $	-96.546	-58 %
22	22 Bailard Foster City, California	121.218 $	+105.909 $	+68.100	Neu
23	23 Commonwealth Equity Services Waltham, Massachusetts	89.000 $	–	–	–
24	24 New York State Common Retirement Fund Albany, New York	80.278 $	-1.089 $	-700	-2 %
25	25 Two Sigma Securities New York	79.164 $	+69.166 $	+44.474	Neu

Protalix BioTherapeutics PLX Börsenwert 205 Mio. $

Protalix BioTherapeutics

PLX

Börsenwert 205 Mio. $